An expert Chrysalis Advisory team, led by Partner Nick Northcott, were engaged by CT:IQ (collaboration of industry, clinical, academic and government partners interested in improving clinical trial impact and quality) to understand to investigate barriers to uptake of eConsent within the Australian clinical trial context and to create actionable insights to support increased adoption. In … Continue reading eConsent in Clinical Trials; Opportunities to enhance patient engagement